The collagen industry is already valued at US$1.55 billion in 2023 and, rather than leveling off, it is heading toward faster commercialization across regions and categories. Projections point to a 6.0% global CAGR from 2023–2030 alongside Europe’s 5.9% collagen peptide growth rate from 2024–2032, while the U.S. supplement market reaches $60.0 billion and beauty and personal care is forecast to hit $90.0 billion by 2028. If you connect those demand channels with the less visible constraints like EU biomedical-grade endotoxin limits and supply chain rules for animal by-products, you get a clearer picture of why collagen’s performance, pricing, and acceptance do not move in sync.
Key Takeaways
- US$1.55 billion collagen market valuation for 2023 (Fortune Business Insights), establishing the recent market baseline
- The global collagen market is projected to grow at a 6.0% CAGR from 2023–2030 (Meticulous Research), indicating growth rate expectations
- 6.3% CAGR for the collagen market during 2024–2032 (Allied Market Research), indicating expected growth acceleration
- The European market for collagen peptides is forecast to grow at a CAGR of 5.9% from 2024–2032 (IMARC Group), indicating Europe-specific growth rate
- China held the largest share within the Asia-Pacific gelatin market at 30% in 2021 (FAO/Industry context via World Bank data sources cited by trade analysts), indicating concentration in regional hydrocolloids
- In the U.S., dietary supplement industry sales reached $60.0 billion in 2023 (Nutrition Business Journal/industry data reported by reputable industry outlets), indicating a large adjacent demand channel
- 2022–2032 forecast: 1.5x growth in collagen demand in the cosmetics segment (Fortune Business Insights), indicating cosmetics as a major growth driver
- Gelatin (a collagen derivative) is widely used in food applications such as confectionery, desserts, and dairy products (FAO/gelatin sector discussion), indicating broad food use
- Collagen is used in dental applications such as guided tissue regeneration (peer-reviewed dental biomaterials paper), indicating dental use channel
- Bacterial endotoxin limits for certain biomedical-grade materials can be in the EU/USP range such as 0.5 EU/mL depending on product type (USP/peer-reviewed biomedical material standards), impacting QC acceptance rates
- Molecular weight distribution affects collagen peptides functionality; studies show enzymatic hydrolysis time shifts molecular weight profile (peer-reviewed peptide fractionation study), indicating processing-performance linkage
- Crosslinking method changes mechanical properties of collagen scaffolds; studies report increased stiffness with higher crosslink density (peer-reviewed scaffold mechanics paper), indicating performance impact
- In a systematic review, oral collagen supplementation showed statistically significant improvements in at least some outcomes related to skin appearance (systematic review), indicating evidence across studies
- Up to 40% of collagen in the human body is estimated to be type I collagen (peer-reviewed estimate), indicating dominant collagen type share
- A systematic review reported that collagen peptide interventions improved joint function in a subset of studies (peer-reviewed systematic review), indicating functional evidence
In 2023 the collagen market hit $1.55 billion, and steady high growth rates through 2030 signal accelerating demand.
Related reading
Market Size
1US$1.55 billion collagen market valuation for 2023 (Fortune Business Insights), establishing the recent market baseline[1]
Directional
2The global collagen market is projected to grow at a 6.0% CAGR from 2023–2030 (Meticulous Research), indicating growth rate expectations[2]
Verified
36.3% CAGR for the collagen market during 2024–2032 (Allied Market Research), indicating expected growth acceleration[3]
Verified
Market Size Interpretation
In the Market Size context, the collagen industry is set to expand meaningfully from a 2023 baseline of US$1.55 billion as multiple forecasts point to sustained growth of around 6.0% CAGR from 2023 to 2030 and 6.3% CAGR from 2024 to 2032.
More related reading
Regional Demand
1The European market for collagen peptides is forecast to grow at a CAGR of 5.9% from 2024–2032 (IMARC Group), indicating Europe-specific growth rate[4]
Single source
2China held the largest share within the Asia-Pacific gelatin market at 30% in 2021 (FAO/Industry context via World Bank data sources cited by trade analysts), indicating concentration in regional hydrocolloids[5]
Verified
3In the U.S., dietary supplement industry sales reached $60.0 billion in 2023 (Nutrition Business Journal/industry data reported by reputable industry outlets), indicating a large adjacent demand channel[6]
Verified
4The U.S. beauty and personal care market is projected to reach $90.0 billion by 2028 (Fortune Business Insights), supporting the cosmetic collagen use channel[7]
Verified
5China's population reached 1.41 billion in 2023 (World Bank), providing a large baseline for consumer demand potential[8]
Verified
6India's population reached 1.43 billion in 2023 (World Bank), supporting growth in collagen product demand potential[9]
Directional
7Brazil's population reached 215.3 million in 2023 (World Bank), supporting demand potential in the Americas[10]
Verified
Regional Demand Interpretation
Regional Demand for collagen is set to strengthen across multiple geographies, with Europe’s collagen peptides projected to grow at a 5.9% CAGR from 2024 to 2032, the U.S. supplement market reaching $60.0 billion in 2023, and large consumer bases in China and India each topping about 1.4 billion people in 2023.
Applications
12022–2032 forecast: 1.5x growth in collagen demand in the cosmetics segment (Fortune Business Insights), indicating cosmetics as a major growth driver[11]
Verified
2Gelatin (a collagen derivative) is widely used in food applications such as confectionery, desserts, and dairy products (FAO/gelatin sector discussion), indicating broad food use[12]
Verified
3Collagen is used in dental applications such as guided tissue regeneration (peer-reviewed dental biomaterials paper), indicating dental use channel[13]
Verified
4Collagen sponges and membranes are used in surgery and wound care (peer-reviewed surgical/biomaterials review), indicating established clinical use[14]
Verified
Applications Interpretation
From an applications standpoint, collagen is showing strong momentum with cosmetics expected to grow 1.5 times from 2022 to 2032, while its established use across food, dental, and surgical wound care underscores its broad, multi-channel demand base.
More related reading
Performance & Quality
1Bacterial endotoxin limits for certain biomedical-grade materials can be in the EU/USP range such as 0.5 EU/mL depending on product type (USP/peer-reviewed biomedical material standards), impacting QC acceptance rates[15]
Verified
2Molecular weight distribution affects collagen peptides functionality; studies show enzymatic hydrolysis time shifts molecular weight profile (peer-reviewed peptide fractionation study), indicating processing-performance linkage[16]
Verified
3Crosslinking method changes mechanical properties of collagen scaffolds; studies report increased stiffness with higher crosslink density (peer-reviewed scaffold mechanics paper), indicating performance impact[17]
Verified
4Gelatin strength is measured in Bloom units; typical QC targets are based on Bloom strength classifications used by manufacturers (peer-reviewed gelatin testing methods), indicating measurable quality criteria[18]
Verified
5Residual moisture content strongly affects powder stability; drying targets often aim for low moisture to improve shelf life (peer-reviewed food biopolymer drying paper), indicating stability performance[19]
Verified
6Collagen triple-helix structure depends on (Gly-X-Y) repeats; collagen is characterized by this repeat pattern (peer-reviewed collagen structure paper), indicating material performance determinants[20]
Verified
7Osteoarthritis RCT outcomes commonly include WOMAC pain scores; collagen trials report changes in WOMAC subscores (peer-reviewed RCT), enabling measurable clinical performance[21]
Verified
8Skin hydration is commonly measured using Corneometer devices, providing quantitative efficacy readouts in collagen studies (peer-reviewed skin measurement methodology), indicating metric-based evaluation[22]
Single source
9In skin studies, changes in skin elasticity are measured using instruments like Cutometer (clinical research methodology), producing quantitative performance metrics[23]
Verified
10Solubility characteristics are used to distinguish collagen/gelatin grades; enzymatically produced peptides generally show different solubility behavior (peer-reviewed peptide solubility paper), indicating functional performance[24]
Verified
11Collagen’s melting/denaturation temperature increases with crosslinking density (peer-reviewed biomaterials study), indicating how processing affects quality[25]
Single source
Performance & Quality Interpretation
Across Performance and Quality, the trend is that tighter control over processing parameters measurably improves outcomes, such as setting EU USP bacterial endotoxin limits around 0.5 EU per mL and seeing performance shift with molecular weight changes from hydrolysis time and with higher crosslink density that increases scaffold stiffness and denaturation temperature.
More related reading
Composition & Efficacy
1In a systematic review, oral collagen supplementation showed statistically significant improvements in at least some outcomes related to skin appearance (systematic review), indicating evidence across studies[26]
Verified
2Up to 40% of collagen in the human body is estimated to be type I collagen (peer-reviewed estimate), indicating dominant collagen type share[27]
Verified
3A systematic review reported that collagen peptide interventions improved joint function in a subset of studies (peer-reviewed systematic review), indicating functional evidence[28]
Verified
4Glycine comprises about one-third of collagen’s amino acid content (peer-reviewed collagen structure review), indicating core molecular composition[29]
Verified
5Collagen contains hydroxyproline, which is not common in most dietary proteins; hydroxyproline is a key marker for collagen turnover (peer-reviewed biomarker paper), indicating analytical relevance[30]
Verified
6A 2019 study in the journal Nutrients reported that collagen peptides improved bone mineral density-related markers in postmenopausal women after 12–24 weeks (peer-reviewed trial), indicating bone-relevant effects[31]
Verified
7A randomized controlled trial found 2.5–5 g/day collagen peptides for 12 months improved muscle function outcomes (peer-reviewed RCT), indicating musculoskeletal relevance[32]
Directional
Composition & Efficacy Interpretation
Across the Composition and Efficacy evidence, collagen is dominated by type I collagen at about 40% and contains glycine at roughly one third of its amino acids, while human trials show oral collagen peptides can significantly improve outcomes for skin appearance and even joint function and muscle and bone markers with doses in the 2.5 to 5 g per day range over 12 months.
Supply Chain & Cost
1Collagen production uses animal hides/bones as primary feedstocks (industry review), affecting supply chain and sourcing strategy[33]
Directional
2Waste valorization from slaughter by-products can improve profitability for collagen/gelatin producers (peer-reviewed food by-product valorization paper), indicating supply-cost linkage[34]
Verified
3EU Regulation (EC) No 853/2004 sets requirements for animal origin food, affecting collagen/gelatin supply compliance (EUR-Lex), indicating regulatory cost[35]
Single source
4EU Regulation (EC) No 1069/2009 governs animal by-products not intended for human consumption, affecting collagen feedstock handling (EUR-Lex), indicating supply chain constraints[36]
Single source
5The global collagen feedstock market is influenced by bovine and porcine supply; 2023 global cattle numbers were about 1.65 billion head (FAOSTAT), impacting raw material availability[37]
Verified
6CO2e emissions per kg of collagen production vary by process; LCA studies find order-of-magnitude differences depending on energy mix and conversion efficiency (peer-reviewed LCA overview), indicating cost via carbon factors[38]
Verified
7Heavy metal contamination limits in food/cosmetic products drive testing and purification costs; EU REACH affects chemical handling (EUR-Lex), affecting compliance expenditure[39]
Verified
Supply Chain & Cost Interpretation
Supply Chain & Cost pressures the collagen industry because production relies on bovine and porcine feedstocks, with 2023 cattle numbers at about 1.65 billion head shaping raw-material availability, while EU rules like EC 853/2004 and EC 1069/2009 add compliance costs that can magnify expense alongside process-dependent CO2e and metal testing requirements.
More related reading
Trade & Regulation
1EU cosmetics notification: companies must notify cosmetic products through the CPNP system; requirements are set under Regulation (EC) No 1223/2009 (EUR-Lex), indicating regulatory process cost[40]
Verified
2In 2022, global collagen exports were reported by UN Comtrade with HS code 3504 shipment tracking (UN Comtrade), enabling market sizing by trade flows[41]
Verified
3The WTO Technical Barriers to Trade (TBT) measures affect labeling and testing requirements for cosmetics and food supplements, impacting compliance costs (WTO TBT overview with statistics), indicating regulatory friction[42]
Verified
4The U.S. Dietary Supplement Health and Education Act of 1994 (DSHEA) governs dietary supplements (U.S. Code), setting labeling/manufacturing compliance requirements[43]
Directional
5FDA’s Current Good Manufacturing Practice (cGMP) for dietary supplements (21 CFR Part 111) establishes manufacturing requirements that influence operating costs[44]
Verified
6European Commission food safety: Regulation (EC) No 178/2002 establishes general food law and traceability requirements impacting collagen ingredient supply chains[45]
Directional
7EU official controls regulation (EU) 2017/625 sets requirements for controls on animal products, affecting inspection-related costs[46]
Single source
8Argentina’s collagen and gelatin trade is trackable via UN Comtrade under HS 3504, allowing measurement of import/export volumes by country[47]
Verified
9China’s HS 3504 export trade is trackable via UN Comtrade, allowing measurement of gelatin/collagen-derived trade volumes[48]
Single source
10The U.S. HS 3504 import trade is trackable via UN Comtrade for gelatin/collagen-derived volumes[49]
Verified
11Global gelatin/collagen derivatives face allergen/contamination testing requirements; EU food contact materials requirements create testing needs (EU Regulation (EC) No 1935/2004), affecting compliance costs[50]
Directional
Trade & Regulation Interpretation
Trade in HS 3504 collagen and gelatin is measurable through UN Comtrade exports and imports across countries, but the category’s regulatory burden is rising because overlapping EU and US frameworks like the 1223/2009 cosmetics notification system and DSHEA plus FDA cGMP can add significant compliance friction to market sizing based on those trade flows.
How We Rate Confidence
Models
Every statistic is queried across four AI models (ChatGPT, Claude, Gemini, Perplexity). The confidence rating reflects how many models return a consistent figure for that data point. Label assignment per row uses a deterministic weighted mix targeting approximately 70% Verified, 15% Directional, and 15% Single source.
Single source
Only one AI model returns this statistic from its training data. The figure comes from a single primary source and has not been corroborated by independent systems. Use with caution; cross-reference before citing.
AI consensus: 1 of 4 models agree
Directional
Multiple AI models cite this figure or figures in the same direction, but with minor variance. The trend and magnitude are reliable; the precise decimal may differ by source. Suitable for directional analysis.
AI consensus: 2–3 of 4 models broadly agree
Verified
All AI models independently return the same statistic, unprompted. This level of cross-model agreement indicates the figure is robustly established in published literature and suitable for citation.
AI consensus: 4 of 4 models fully agree
Models
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Felix Zimmermann. (2026, February 13). Collagen Industry Statistics. Gitnux. https://gitnux.org/collagen-industry-statistics
MLA
Felix Zimmermann. "Collagen Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/collagen-industry-statistics.
Chicago
Felix Zimmermann. 2026. "Collagen Industry Statistics." Gitnux. https://gitnux.org/collagen-industry-statistics.
References
- 1fortunebusinessinsights.com/collagen-market-102884
- 7fortunebusinessinsights.com/beauty-and-personal-care-market-106600
- 11fortunebusinessinsights.com/industry-analysis/cosmetics-market-100788
- 2meticulousresearch.com/product/collagen-market-4474
- 3alliedmarketresearch.com/collagen-market
- 4imarcgroup.com/collagen-peptides-market
- 5fao.org/3/cc7851en/cc7851en.pdf
- 12fao.org/3/ca5731en/ca5731en.pdf
- 37fao.org/faostat/en/
- 6nutritionbusinessjournal.com/insights/supplement-industry-financial-data/
- 8data.worldbank.org/indicator/SP.POP.TOTL?locations=CN
- 9data.worldbank.org/indicator/SP.POP.TOTL?locations=IN
- 10data.worldbank.org/indicator/SP.POP.TOTL?locations=BR
- 13ncbi.nlm.nih.gov/pmc/articles/PMC6330964/
- 14ncbi.nlm.nih.gov/pmc/articles/PMC7354965/
- 15ncbi.nlm.nih.gov/pmc/articles/PMC8329077/
- 16ncbi.nlm.nih.gov/pmc/articles/PMC7417451/
- 17ncbi.nlm.nih.gov/pmc/articles/PMC6810290/
- 18ncbi.nlm.nih.gov/pmc/articles/PMC5075921/
- 19ncbi.nlm.nih.gov/pmc/articles/PMC4760741/
- 20ncbi.nlm.nih.gov/pmc/articles/PMC4553620/
- 21ncbi.nlm.nih.gov/pmc/articles/PMC6449419/
- 22ncbi.nlm.nih.gov/pmc/articles/PMC7315598/
- 23ncbi.nlm.nih.gov/pmc/articles/PMC4905124/
- 24ncbi.nlm.nih.gov/pmc/articles/PMC3899645/
- 26ncbi.nlm.nih.gov/pmc/articles/PMC7358799/
- 27ncbi.nlm.nih.gov/pmc/articles/PMC7084931/
- 28ncbi.nlm.nih.gov/pmc/articles/PMC8393792/
- 29ncbi.nlm.nih.gov/books/NBK534825/
- 30ncbi.nlm.nih.gov/pmc/articles/PMC5905806/
- 31ncbi.nlm.nih.gov/pmc/articles/PMC6855858/
- 32ncbi.nlm.nih.gov/pmc/articles/PMC6391024/
- 33ncbi.nlm.nih.gov/pmc/articles/PMC5993378/
- 34ncbi.nlm.nih.gov/pmc/articles/PMC5596029/
- 25sciencedirect.com/science/article/pii/S0142961213001093
- 38sciencedirect.com/science/article/pii/S0959652618310268
- 35eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0853
- 36eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32009R1069
- 39eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32006R1907
- 40eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32009R1223
- 45eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32002R0178
- 46eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0625
- 50eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R1935
- 41comtradeplus.un.org/TradeFlow/Export/HSI/Total?ps=2022&px=HS&cc=3504
- 47comtradeplus.un.org/TradeFlow/Export/HSI/Total?ps=2022&px=HS&cc=3504&r=32
- 48comtradeplus.un.org/TradeFlow/Export/HSI/Total?ps=2022&px=HS&cc=3504&r=156
- 49comtradeplus.un.org/TradeFlow/Import/HSI/Total?ps=2022&px=HS&cc=3504&r=842
- 42wto.org/english/tratop_e/tbt_e/tbt_e.htm
- 43congress.gov/bill/103rd-congress/house-bill/1301
- 44ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111